 | • レポートコード：GIR-107A12027 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、養子細胞療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。養子細胞療法の種類別市場規模（CAR-T、TCR-T、NK、TIL）、用途別市場規模（リンパ腫、白血病）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・養子細胞療法の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis、Juno、Kite、Adaptimmune、Fibrocell、Lineage Cell Therapeutics、BioTime、Vericel Corporation、Regeneus、Anhui Anke Biotechnology、Cellectis、NantKwest、SorrentoTherapeutics、Bellicum ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：CAR-T、TCR-T、NK、TIL ・用途別分析2016年-2026年：リンパ腫、白血病 ・養子細胞療法の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・養子細胞療法のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・養子細胞療法のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・養子細胞療法の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・養子細胞療法の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Adoptive Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Adoptive Cell Therapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Adoptive Cell Therapy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Adoptive Cell Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CAR-T
TCR-T
NK
TIL
Market segment by Application, can be divided into
Lymphoma
Leukemia
Market segment by players, this report covers
Novartis
Juno
Kite
Adaptimmune
Fibrocell
Lineage Cell Therapeutics
BioTime
Vericel Corporation
Regeneus
Anhui Anke Biotechnology
Cellectis
NantKwest
SorrentoTherapeutics
Bellicum
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Adoptive Cell Therapy
1.2 Classification of Adoptive Cell Therapy by Type
1.2.1 Overview: Global Adoptive Cell Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Adoptive Cell Therapy Revenue Market Share by Type in 2020
1.2.3 CAR-T
1.2.4 TCR-T
1.2.5 NK
1.2.6 TIL
1.3 Global Adoptive Cell Therapy Market by Application
1.3.1 Overview: Global Adoptive Cell Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Lymphoma
1.3.3 Leukemia
1.4 Global Adoptive Cell Therapy Market Size & Forecast
1.5 Global Adoptive Cell Therapy Market Size and Forecast by Region
1.5.1 Global Adoptive Cell Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Adoptive Cell Therapy Market Size by Region, (2016-2021)
1.5.3 North America Adoptive Cell Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Adoptive Cell Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Adoptive Cell Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Adoptive Cell Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Adoptive Cell Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Adoptive Cell Therapy Market Drivers
1.6.2 Adoptive Cell Therapy Market Restraints
1.6.3 Adoptive Cell Therapy Trends Analysis
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Adoptive Cell Therapy Product and Solutions
2.1.4 Novartis Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Juno
2.2.1 Juno Details
2.2.2 Juno Major Business
2.2.3 Juno Adoptive Cell Therapy Product and Solutions
2.2.4 Juno Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Juno Recent Developments and Future Plans
2.3 Kite
2.3.1 Kite Details
2.3.2 Kite Major Business
2.3.3 Kite Adoptive Cell Therapy Product and Solutions
2.3.4 Kite Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Kite Recent Developments and Future Plans
2.4 Adaptimmune
2.4.1 Adaptimmune Details
2.4.2 Adaptimmune Major Business
2.4.3 Adaptimmune Adoptive Cell Therapy Product and Solutions
2.4.4 Adaptimmune Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Adaptimmune Recent Developments and Future Plans
2.5 Fibrocell
2.5.1 Fibrocell Details
2.5.2 Fibrocell Major Business
2.5.3 Fibrocell Adoptive Cell Therapy Product and Solutions
2.5.4 Fibrocell Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Fibrocell Recent Developments and Future Plans
2.6 Lineage Cell Therapeutics
2.6.1 Lineage Cell Therapeutics Details
2.6.2 Lineage Cell Therapeutics Major Business
2.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Product and Solutions
2.6.4 Lineage Cell Therapeutics Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Lineage Cell Therapeutics Recent Developments and Future Plans
2.7 BioTime
2.7.1 BioTime Details
2.7.2 BioTime Major Business
2.7.3 BioTime Adoptive Cell Therapy Product and Solutions
2.7.4 BioTime Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 BioTime Recent Developments and Future Plans
2.8 Vericel Corporation
2.8.1 Vericel Corporation Details
2.8.2 Vericel Corporation Major Business
2.8.3 Vericel Corporation Adoptive Cell Therapy Product and Solutions
2.8.4 Vericel Corporation Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Vericel Corporation Recent Developments and Future Plans
2.9 Regeneus
2.9.1 Regeneus Details
2.9.2 Regeneus Major Business
2.9.3 Regeneus Adoptive Cell Therapy Product and Solutions
2.9.4 Regeneus Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Regeneus Recent Developments and Future Plans
2.10 Anhui Anke Biotechnology
2.10.1 Anhui Anke Biotechnology Details
2.10.2 Anhui Anke Biotechnology Major Business
2.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Product and Solutions
2.10.4 Anhui Anke Biotechnology Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Anhui Anke Biotechnology Recent Developments and Future Plans
2.11 Cellectis
2.11.1 Cellectis Details
2.11.2 Cellectis Major Business
2.11.3 Cellectis Adoptive Cell Therapy Product and Solutions
2.11.4 Cellectis Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Cellectis Recent Developments and Future Plans
2.12 NantKwest
2.12.1 NantKwest Details
2.12.2 NantKwest Major Business
2.12.3 NantKwest Adoptive Cell Therapy Product and Solutions
2.12.4 NantKwest Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 NantKwest Recent Developments and Future Plans
2.13 SorrentoTherapeutics
2.13.1 SorrentoTherapeutics Details
2.13.2 SorrentoTherapeutics Major Business
2.13.3 SorrentoTherapeutics Adoptive Cell Therapy Product and Solutions
2.13.4 SorrentoTherapeutics Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 SorrentoTherapeutics Recent Developments and Future Plans
2.14 Bellicum
2.14.1 Bellicum Details
2.14.2 Bellicum Major Business
2.14.3 Bellicum Adoptive Cell Therapy Product and Solutions
2.14.4 Bellicum Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Bellicum Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Adoptive Cell Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Adoptive Cell Therapy Players Market Share
3.2.2 Top 10 Adoptive Cell Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Adoptive Cell Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Adoptive Cell Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Adoptive Cell Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Adoptive Cell Therapy Revenue Market Share by Application (2016-2021)
5.2 Adoptive Cell Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Adoptive Cell Therapy Revenue by Type (2016-2026)
6.2 North America Adoptive Cell Therapy Revenue by Application (2016-2026)
6.3 North America Adoptive Cell Therapy Market Size by Country
6.3.1 North America Adoptive Cell Therapy Revenue by Country (2016-2026)
6.3.2 United States Adoptive Cell Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Adoptive Cell Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Adoptive Cell Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Adoptive Cell Therapy Revenue by Type (2016-2026)
7.2 Europe Adoptive Cell Therapy Revenue by Application (2016-2026)
7.3 Europe Adoptive Cell Therapy Market Size by Country
7.3.1 Europe Adoptive Cell Therapy Revenue by Country (2016-2026)
7.3.2 Germany Adoptive Cell Therapy Market Size and Forecast (2016-2026)
7.3.3 France Adoptive Cell Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Adoptive Cell Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Adoptive Cell Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Adoptive Cell Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Adoptive Cell Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Adoptive Cell Therapy Market Size by Region
8.3.1 Asia-Pacific Adoptive Cell Therapy Revenue by Region (2016-2026)
8.3.2 China Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8.3.5 India Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Adoptive Cell Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Adoptive Cell Therapy Revenue by Type (2016-2026)
9.2 South America Adoptive Cell Therapy Revenue by Application (2016-2026)
9.3 South America Adoptive Cell Therapy Market Size by Country
9.3.1 South America Adoptive Cell Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Adoptive Cell Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Adoptive Cell Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Adoptive Cell Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Adoptive Cell Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Adoptive Cell Therapy Market Size by Country
10.3.1 Middle East & Africa Adoptive Cell Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Adoptive Cell Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Adoptive Cell Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Adoptive Cell Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Adoptive Cell Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Adoptive Cell Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Adoptive Cell Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Adoptive Cell Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Adoptive Cell Therapy Revenue Market Share by Region (2021-2026)
Table 6. Novartis Corporate Information, Head Office, and Major Competitors
Table 7. Novartis Major Business
Table 8. Novartis Adoptive Cell Therapy Product and Solutions
Table 9. Novartis Adoptive Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Juno Corporate Information, Head Office, and Major Competitors
Table 11. Juno Major Business
Table 12. Juno Adoptive Cell Therapy Product and Solutions
Table 13. Juno Adoptive Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Kite Corporate Information, Head Office, and Major Competitors
Table 15. Kite Major Business
Table 16. Kite Adoptive Cell Therapy Product and Solutions
Table 17. Kite Adoptive Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Adaptimmune Corporate Information, Head Office, and Major Competitors
Table 19. Adaptimmune Major Business
Table 20. Adaptimmune Adoptive Cell Therapy Product and Solutions
Table 21. Adaptimmune Adoptive Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Fibrocell Corporate Information, Head Office, and Major Competitors
Table 23. Fibrocell Major Business
Table 24. Fibrocell Adoptive Cell Therapy Product and Solutions
Table 25. Fibrocell Adoptive Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Lineage Cell Therapeutics Corporate Information, Head Office, and Major Competitors
Table 27. Lineage Cell Therapeutics Major Business
Table 28. Lineage Cell Therapeutics Adoptive Cell Therapy Product and Solutions
Table 29. Lineage Cell Therapeutics Adoptive Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. BioTime Corporate Information, Head Office, and Major Competitors
Table 31. BioTime Major Business
Table 32. BioTime Adoptive Cell Therapy Product and Solutions
Table 33. BioTime Adoptive Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Vericel Corporation Corporate Information, Head Office, and Major Competitors
Table 35. Vericel Corporation Major Business
Table 36. Vericel Corporation Adoptive Cell Therapy Product and Solutions
Table 37. Vericel Corporation Adoptive Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Regeneus Corporate Information, Head Office, and Major Competitors
Table 39. Regeneus Major Business
Table 40. Regeneus Adoptive Cell Therapy Product and Solutions
Table 41. Regeneus Adoptive Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Anhui Anke Biotechnology Corporate Information, Head Office, and Major Competitors
Table 43. Anhui Anke Biotechnology Major Business
Table 44. Anhui Anke Biotechnology Adoptive Cell Therapy Product and Solutions
Table 45. Anhui Anke Biotechnology Adoptive Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Cellectis Corporate Information, Head Office, and Major Competitors
Table 47. Cellectis Major Business
Table 48. Cellectis Adoptive Cell Therapy Product and Solutions
Table 49. Cellectis Adoptive Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. NantKwest Corporate Information, Head Office, and Major Competitors
Table 51. NantKwest Major Business
Table 52. NantKwest Adoptive Cell Therapy Product and Solutions
Table 53. NantKwest Adoptive Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. SorrentoTherapeutics Corporate Information, Head Office, and Major Competitors
Table 55. SorrentoTherapeutics Major Business
Table 56. SorrentoTherapeutics Adoptive Cell Therapy Product and Solutions
Table 57. SorrentoTherapeutics Adoptive Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Bellicum Corporate Information, Head Office, and Major Competitors
Table 59. Bellicum Major Business
Table 60. Bellicum Adoptive Cell Therapy Product and Solutions
Table 61. Bellicum Adoptive Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Adoptive Cell Therapy Revenue (USD Million) by Players (2019-2021)
Table 63. Global Adoptive Cell Therapy Revenue Share by Players (2019-2021)
Table 64. Breakdown of Adoptive Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Adoptive Cell Therapy Players Head Office, Products and Services Provided
Table 66. Adoptive Cell Therapy Mergers & Acquisitions in the Past Five Years
Table 67. Adoptive Cell Therapy New Entrants and Expansion Plans
Table 68. Global Adoptive Cell Therapy Revenue (USD Million) by Type (2016-2021)
Table 69. Global Adoptive Cell Therapy Revenue Share by Type (2016-2021)
Table 70. Global Adoptive Cell Therapy Revenue Forecast by Type (2021-2026)
Table 71. Global Adoptive Cell Therapy Revenue by Application (2016-2021)
Table 72. Global Adoptive Cell Therapy Revenue Forecast by Application (2021-2026)
Table 73. North America Adoptive Cell Therapy Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Adoptive Cell Therapy Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Adoptive Cell Therapy Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Adoptive Cell Therapy Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Adoptive Cell Therapy Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Adoptive Cell Therapy Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Adoptive Cell Therapy Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Adoptive Cell Therapy Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Adoptive Cell Therapy Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Adoptive Cell Therapy Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Adoptive Cell Therapy Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Adoptive Cell Therapy Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Adoptive Cell Therapy Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Adoptive Cell Therapy Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Adoptive Cell Therapy Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Adoptive Cell Therapy Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Adoptive Cell Therapy Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Adoptive Cell Therapy Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Adoptive Cell Therapy Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Adoptive Cell Therapy Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Adoptive Cell Therapy Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Adoptive Cell Therapy Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Adoptive Cell Therapy Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Adoptive Cell Therapy Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Adoptive Cell Therapy Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Adoptive Cell Therapy Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Adoptive Cell Therapy Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Adoptive Cell Therapy Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Adoptive Cell Therapy Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Adoptive Cell Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Adoptive Cell Therapy Picture
Figure 2. Global Adoptive Cell Therapy Revenue Market Share by Type in 2020
Figure 3. CAR-T
Figure 4. TCR-T
Figure 5. NK
Figure 6. TIL
Figure 7. Adoptive Cell Therapy Revenue Market Share by Application in 2020
Figure 8. Lymphoma Picture
Figure 9. Leukemia Picture
Figure 10. Global Adoptive Cell Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Adoptive Cell Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Adoptive Cell Therapy Revenue Market Share by Region (2016-2026)
Figure 13. Global Adoptive Cell Therapy Revenue Market Share by Region in 2020
Figure 14. North America Adoptive Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Adoptive Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Adoptive Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Adoptive Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Adoptive Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Adoptive Cell Therapy Market Drivers
Figure 20. Adoptive Cell Therapy Market Restraints
Figure 21. Adoptive Cell Therapy Market Trends
Figure 22. Novartis Recent Developments and Future Plans
Figure 23. Juno Recent Developments and Future Plans
Figure 24. Kite Recent Developments and Future Plans
Figure 25. Adaptimmune Recent Developments and Future Plans
Figure 26. Fibrocell Recent Developments and Future Plans
Figure 27. Lineage Cell Therapeutics Recent Developments and Future Plans
Figure 28. BioTime Recent Developments and Future Plans
Figure 29. Vericel Corporation Recent Developments and Future Plans
Figure 30. Regeneus Recent Developments and Future Plans
Figure 31. Anhui Anke Biotechnology Recent Developments and Future Plans
Figure 32. Cellectis Recent Developments and Future Plans
Figure 33. NantKwest Recent Developments and Future Plans
Figure 34. SorrentoTherapeutics Recent Developments and Future Plans
Figure 35. Bellicum Recent Developments and Future Plans
Figure 36. Global Adoptive Cell Therapy Revenue Share by Players in 2020
Figure 37. Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Adoptive Cell Therapy Revenue Market Share in 2020
Figure 39. Global Top 10 Players Adoptive Cell Therapy Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Adoptive Cell Therapy Revenue Share by Type in 2020
Figure 42. Global Adoptive Cell Therapy Market Share Forecast by Type (2021-2026)
Figure 43. Global Adoptive Cell Therapy Revenue Share by Application in 2020
Figure 44. Global Adoptive Cell Therapy Market Share Forecast by Application (2021-2026)
Figure 45. North America Adoptive Cell Therapy Sales Market Share by Type (2016-2026)
Figure 46. North America Adoptive Cell Therapy Sales Market Share by Application (2016-2026)
Figure 47. North America Adoptive Cell Therapy Revenue Market Share by Country (2016-2026)
Figure 48. United States Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Adoptive Cell Therapy Sales Market Share by Type (2016-2026)
Figure 52. Europe Adoptive Cell Therapy Sales Market Share by Application (2016-2026)
Figure 53. Europe Adoptive Cell Therapy Revenue Market Share by Country (2016-2026)
Figure 54. Germany Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Adoptive Cell Therapy Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Adoptive Cell Therapy Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Adoptive Cell Therapy Revenue Market Share by Region (2016-2026)
Figure 62. China Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Adoptive Cell Therapy Sales Market Share by Type (2016-2026)
Figure 69. South America Adoptive Cell Therapy Sales Market Share by Application (2016-2026)
Figure 70. South America Adoptive Cell Therapy Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Adoptive Cell Therapy Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Adoptive Cell Therapy Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Adoptive Cell Therapy Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Adoptive Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の養子細胞免疫療法市場 2021：企業別、地域別、種類・用途別 The Adoptive Cellular Immunotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…- 世界のT細胞療法市場 2021：企業別、地域別、種類・用途別 The T-Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界の細胞治療バイオプロセシング市場 2021：企業別、地域別、種類・用途別 The Cell Therapy Bioprocessing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界の不死化細胞株市場 2021：企業別、地域別、種類・用途別 The Immortalized Cell Line market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界のTCR-T治療試薬市場 2021：企業別、地域別、種類・用途別 The TCR-T Therapy Reagent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…